Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson.

Lim JU, Lin HY, Kang L, Le H, Tang TY, Champiat S, Dumbrava EE, Le X, Naing A, Piha-Paul SA, Ahnert JR, Tsimberidou AM, Yap TA, Fu S, Meric-Bernstam F, Hong DS

Open source

DOI: 10.1038/s41698-025-01261-5
Published: 2026 Jan 13
Container: NPJ precision oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41698-025-01261-5,
  title = {Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson.},
  author = {Lim JU and Lin HY and Kang L and Le H and Tang TY and Champiat S and Dumbrava EE and Le X and Naing A and Piha-Paul SA and Ahnert JR and Tsimberidou AM and Yap TA and Fu S and Meric-Bernstam F and Hong DS},
  year = {2026},
  journal = {NPJ precision oncology},
  doi = {10.1038/s41698-025-01261-5},
  url = {https://doi.org/10.1038/s41698-025-01261-5}
}

RIS

TY  - JOUR
TI  - Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson.
AU  - Lim JU
AU  - Lin HY
AU  - Kang L
AU  - Le H
AU  - Tang TY
AU  - Champiat S
AU  - Dumbrava EE
AU  - Le X
AU  - Naing A
AU  - Piha-Paul SA
AU  - Ahnert JR
AU  - Tsimberidou AM
AU  - Yap TA
AU  - Fu S
AU  - Meric-Bernstam F
AU  - Hong DS
PY  - 2026
JO  - NPJ precision oncology
DO  - 10.1038/s41698-025-01261-5
UR  - https://doi.org/10.1038/s41698-025-01261-5
ER  -

APA

JU, L., HY, L., L, K., H, L., TY, T., S, C., EE, D., X, L., A, N., SA, P., JR, A., AM, T., TA, Y., S, F., F, M., & DS, H. (2026). Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson.. NPJ precision oncology. https://doi.org/10.1038/s41698-025-01261-5

Source records

pubmed · retrieved 2026-09-27T00:05:00.983Z